Earnings per share (EPS) was mostly in line with analyst estimates. Looking ahead, revenue is forecast to grow 38% p.a. on ...

This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.

These new supplemental products are offering similar benefits to drugs like Ozempic — but experts say it may be a placebo effect.

Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ETCompany ParticipantsKhalid Waleed Hosny ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Harrow has received a total of 2 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $68.0, the consensus suggests a potential 104.76% upside.

Indian exporters who built their businesses on Americans’ demand for affordable goods are redrawing their strategies and weighing alternatives to reduce the pain from Trump’s shock 50% levy on imports ...

AbbVie’s Skyrizi tallied the most TV impressions among pharma brands in July, rising from second in June. The psoriasis treatment achieved a share of voice (SOV) of 4.61% with 2.5 billion impressions.

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

Apple Inc suppliers Foxconn Hon Hai, Tata Electronics, Pegatron Corp and Wistron Infocomm are the largest exporters from ...

By Leah Olson, Vice President of Growth Strategy at Bluedog Design, and Cody Wells, Creative Strategy Director at Bluedog ...